Immunoglobulin-specific radioimmunoprecipitation assays for quantitation of nasal secretory antibodies to hemagglutinin of type A influenza viruses
- PMID: 100506
- PMCID: PMC275182
- DOI: 10.1128/jcm.8.2.171-176.1978
Immunoglobulin-specific radioimmunoprecipitation assays for quantitation of nasal secretory antibodies to hemagglutinin of type A influenza viruses
Abstract
Radioimmunoprecipitation (RIP) assays were developed to selectively quantitate class-specific antibodies to purified hemagglutinins (HA) of type A influenza virus in nasal secretions. Rabbit anti-human secretory piece of immunoglobulin A (IgA) and rabbit anti-human IgG were used as second antibodies. A third antibody, goat anti-rabbit IgG, was incorporated into the system to separate immune complexes formed between iodinated HA, nasal wash test specimen, and second antibody. The utilization of this reagent avoided the need for large quantities of IgA and IgG antibody-negative carrier secretions. Nasal was specimens obtained from 14 adults immunized with an inactivated type A influenza virus vaccine were evaluated by RIP and viral neutralization assays. Significant homologous postvaccination secretory IgA and IgG antibody levels were demonstrable in 13 (93%) of individuals by RIP, whereas only 5 (36%) exhibited rises by viral neutralization tests. Moreover, the geometric mean IgA and IgG antibody levels were at least 20- and 37-fold greater than the neutralizing antibody titer. The pattern of heterologous immunoglobulin-specific antibody responses tended to be similar to those observed with the homologous HA subunit.
Similar articles
-
Analysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum.J Clin Microbiol. 1987 Mar;25(3):559-62. doi: 10.1128/jcm.25.3.559-562.1987. J Clin Microbiol. 1987. PMID: 3571460 Free PMC article.
-
Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines.Infect Immun. 1982 Jun;36(3):1102-8. doi: 10.1128/iai.36.3.1102-1108.1982. Infect Immun. 1982. PMID: 7095844 Free PMC article.
-
Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules.Eur J Immunol. 1991 Jun;21(6):1337-44. doi: 10.1002/eji.1830210602. Eur J Immunol. 1991. PMID: 1646112
-
Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?Jpn J Infect Dis. 2016;69(3):165-79. doi: 10.7883/yoken.JJID.2015.560. Jpn J Infect Dis. 2016. PMID: 27212584 Review.
-
How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions.Influenza Other Respir Viruses. 2019 Sep;13(5):429-437. doi: 10.1111/irv.12664. Epub 2019 Jun 21. Influenza Other Respir Viruses. 2019. PMID: 31225704 Free PMC article. Review.
Cited by
-
Solid-phase radioimmunoassay of serum immunoglobulin A antibodies to respiratory syncytial virus and adenovirus.J Clin Microbiol. 1979 Aug;10(2):192-7. doi: 10.1128/jcm.10.2.192-197.1979. J Clin Microbiol. 1979. PMID: 511988 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous